» Articles » PMID: 38335956

Integrative High-throughput Enhancer Surveying and Functional Verification Divulges a YY2-condensed Regulatory Axis Conferring Risk for Osteoporosis

Abstract

The precise roles of chromatin organization at osteoporosis risk loci remain largely elusive. Here, we combined chromatin interaction conformation (Hi-C) profiling and self-transcribing active regulatory region sequencing (STARR-seq) to qualify enhancer activities of prioritized osteoporosis-associated single-nucleotide polymorphisms (SNPs). We identified 319 SNPs with biased allelic enhancer activity effect (baaSNPs) that linked to hundreds of candidate target genes through chromatin interactions across 146 loci. Functional characterizations revealed active epigenetic enrichment for baaSNPs and prevailing osteoporosis-relevant regulatory roles for their chromatin interaction genes. Further motif enrichment and network mapping prioritized several putative, key transcription factors (TFs) controlling osteoporosis binding to baaSNPs. Specifically, we selected one top-ranked TF and deciphered that an intronic baaSNP (rs11202530) could allele-preferentially bind to YY2 to augment PAPSS2 expression through chromatin interactions and promote osteoblast differentiation. Our results underline the roles of TF-mediated enhancer-promoter contacts for osteoporosis, which may help to better understand the intricate molecular regulatory mechanisms underlying osteoporosis risk loci.

Citing Articles

RUNX2 Phase Separation Mediates Long-Range Regulation Between Osteoporosis-Susceptibility Variant and XCR1 to Promote Osteoblast Differentiation.

Zhang Y, Li X, Peng P, Qiu Z, Di C, Chen X Adv Sci (Weinh). 2024; 12(6):e2413561.

PMID: 39704037 PMC: 11809430. DOI: 10.1002/advs.202413561.

References
1.
Lu L, Liu X, Huang W, Giusti-Rodriguez P, Cui J, Zhang S . Robust Hi-C Maps of Enhancer-Promoter Interactions Reveal the Function of Non-coding Genome in Neural Development and Diseases. Mol Cell. 2020; 79(3):521-534.e15. PMC: 7415676. DOI: 10.1016/j.molcel.2020.06.007. View

2.
Zhu D, Chen X, Hu W, Dong S, Lu B, Rong Y . Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer. J Bone Miner Res. 2018; 33(7):1335-1346. DOI: 10.1002/jbmr.3419. View

3.
Trajanoska K, Morris J, Oei L, Zheng H, Evans D, Kiel D . Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study. BMJ. 2018; 362:k3225. PMC: 6113773. DOI: 10.1136/bmj.k3225. View

4.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

5.
Kulakovskiy I, Vorontsov I, Yevshin I, Sharipov R, Fedorova A, Rumynskiy E . HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acids Res. 2017; 46(D1):D252-D259. PMC: 5753240. DOI: 10.1093/nar/gkx1106. View